Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

Cumberland Pharmaceuticals has reported positive outcomes from a trial of ifetroban as a potential treatment for Duchenne ...

On World Cancer Day, the UK Government has announced plans to launch a national trial to cut cancer screening wait times.

In the Phase II MAIA lung cancer trial, THIO improved patients’ overall survival when taken in combination with Libtayo.

Makerere University, the Uganda Virus Research Institute and the WHO got the Uganda Ebola vaccine trial ready for dosing in ...

PhaseV has formed a strategic collaboration with Alimentiv for supporting the design and execution of adaptive clinical ...

Aplagon has secured a financing of €7m ($7.24m) to advance APAC, to primarily support the initiation of a Phase IIa trial for ...

In partnership with global institutions, IIT Guwahati researchers have developed an adaptive multi-stage trial method.

Entrada has secured authorisation from the UK's MHRA to commence ELEVATE-44-201, to evaluate ENTR-601-44, aimed at treating DMD.

The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.

Experts believe that pharma will continue as normal due to the scientific justification of running diverse clinical trials.